These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3803876)

  • 1. [Significance of atypical hemorrhage in ovarian cancer].
    Schulz BO; Baker E; Krebs D; Oberheuser F; Werner A
    Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):811-2. PubMed ID: 3803876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulosa cell tumors of the ovary: prognostic factors and outcome.
    Malmström H; Högberg T; Risberg B; Simonsen E
    Gynecol Oncol; 1994 Jan; 52(1):50-5. PubMed ID: 8307501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
    Ma SK; Zhang HT; Sun YC; Wu LY
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of a sarcomatous component outside the ovary is an adverse prognostic factor for primary ovarian malignant mixed mesodermal/mullerian tumors: a clinicopathologic study of 47 cases.
    Kunkel J; Peng Y; Tao Y; Krigman H; Cao D
    Am J Surg Pathol; 2012 Jun; 36(6):831-7. PubMed ID: 22588065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic insight of simultaneously detected primary endometrial and ovarian carcinomas.
    Rodolakis A; Thomakos N; Akrivos N; Sotiropoulou M; Ioannidis I; Haidopoulos D; Vlachos G; Antsaklis A
    Arch Gynecol Obstet; 2012 Mar; 285(3):817-21. PubMed ID: 21842403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
    Cuff J; Longacre TA
    Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study.
    Erzen M; Rakar S; Klancnik B; Syrjänen K
    Gynecol Oncol; 2001 Oct; 83(1):100-8. PubMed ID: 11585420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronous primary cancers of the endometrium and ovary: a single institution review of 84 cases.
    Soliman PT; Slomovitz BM; Broaddus RR; Sun CC; Oh JC; Eifel PJ; Gershenson DM; Lu KH
    Gynecol Oncol; 2004 Aug; 94(2):456-62. PubMed ID: 15297188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Grading of epithelial ovarian cancers].
    Schulz BO; Baker E; Strolz C; Sellin D; Stegner HL; Krebs D
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):11-6. PubMed ID: 2984082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers.
    Chan JK; Teoh D; Hu JM; Shin JY; Osann K; Kapp DS
    Gynecol Oncol; 2008 Jun; 109(3):370-6. PubMed ID: 18395777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.
    Mangili G; Bergamini A; Taccagni G; Gentile C; Panina P; Viganò P; Candiani M
    Gynecol Oncol; 2012 Sep; 126(3):403-7. PubMed ID: 22609111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural history and outcome of mucinous carcinoma of the ovary.
    Schiavone MB; Herzog TJ; Lewin SN; Deutsch I; Sun X; Burke WM; Wright JD
    Am J Obstet Gynecol; 2011 Nov; 205(5):480.e1-8. PubMed ID: 21861962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexisting endometrial and ovarian carcinomas: a retrospective clinicopathological study.
    Caldarella A; Crocetti E; Taddei GL; Paci E
    Pathol Res Pract; 2008; 204(9):643-8. PubMed ID: 18472354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian hemangioma presenting with hyperandrogenism and endometrial cancer: a case report.
    Gücer F; Ozyilmaz F; Balkanli-Kaplan P; Mülayim N; Aydin O
    Gynecol Oncol; 2004 Sep; 94(3):821-4. PubMed ID: 15350380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclic bleeding during menopause in ovarian adenofibromas].
    Bernard A; Klímová R
    Cesk Gynekol; 1966 Feb; 31(1):38-40. PubMed ID: 5930100
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysterectomy for recurrent postmenopausal bleeding revisited: missed sclerosing stromal ovarian tumour.
    Chung JP; Cheung EC; Yim SF; Mak SM
    Hong Kong Med J; 2012 Aug; 18(4):338-9. PubMed ID: 22865180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer.
    Gamzatova Z; Villabona L; Dahlgren L; Dalianis T; Nillson B; Bergfeldt K; Masucci GV
    Gynecol Oncol; 2006 Oct; 103(1):145-50. PubMed ID: 16542716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.